No single flea and tick treatment is universally the “safest” for every dog. The best choice depends on your dog’s breed, age, weight, and health history. That said, most FDA-approved flea and tick products have strong safety records when used correctly, and the differences between them come down to specific risk factors that vary from dog to dog.
Understanding what’s in these products and which dogs face higher risks will help you make a confident choice.
How the Main Treatment Types Compare
Flea and tick products fall into a few broad categories, each with a different safety profile.
Oral chewables (isoxazolines) are the most popular modern option. Products like Bravecto, NexGard, Simparica, and Credelio all use isoxazoline-class drugs that circulate in your dog’s bloodstream and kill parasites when they bite. These work well and are convenient, but the FDA has flagged them for a specific concern: neurologic adverse reactions, including muscle tremors, loss of coordination, and seizures. Most dogs tolerate them fine, but seizures can occur even in dogs with no prior history. If your dog has a seizure disorder or a history of neurologic problems, these products carry more risk.
Topical spot-on treatments like fipronil-based products (Frontline) sit on the skin and coat rather than entering the bloodstream in significant amounts. Fipronil targets insect nerve receptors with high selectivity: insects are 700 to 1,300 times more sensitive to it than mammals. This wide safety margin is one reason topicals have been a go-to for decades. The tradeoff is that topicals can cause skin irritation at the application site, they take longer to spread across the body, and the active ingredient can transfer to furniture, people, and waterways when your dog gets wet or you pet them.
Flea and tick collars release active ingredients slowly over months. The Seresto collar, one of the most widely used, underwent an in-depth EPA review starting in 2021 after a high volume of incident reports. The EPA analyzed roughly 1,400 reported deaths from 2016 to 2020, which made up about 2 percent of all Seresto incidents in that period. The only deaths found to be “probably” or “definitely” related to the collar involved mechanical strangulation or trauma from a failure of the collar’s release mechanism, not the pesticide itself. Some non-lethal incidents did show neurological symptoms that improved when the collar was removed and returned when it was reapplied. The collar remains on the market and meets federal safety standards, but if your dog shows any unusual symptoms after wearing one, removing it is the obvious first step.
Breeds That Need Extra Caution
Some dogs carry a genetic variant called MDR1 that affects how their bodies process certain drugs. The variant is most common in herding breeds: Collies, Australian Shepherds, American Shepherds, German Shepherds, Shetland Sheepdogs, and Old English Sheepdogs, among others. Dogs with this variant can experience toxicity from medications that are perfectly safe for other breeds.
For flea and tick prevention specifically, the biggest MDR1 concern involves drug interactions rather than the preventatives themselves. Spinosad (the active ingredient in Comfortis), when combined with certain other medications like cyclosporine or ketoconazole, can increase drug concentrations in the body and raise the risk of adverse reactions, even in dogs without the genetic variant. Ivermectin, commonly used in heartworm preventatives, is safe at low FDA-approved doses but dangerous at higher ones for MDR1-sensitive dogs.
If you have a herding breed or a mixed breed with herding ancestry, a simple genetic test can tell you whether your dog carries the MDR1 variant. That result helps your vet choose products and doses with confidence.
Why “Natural” Doesn’t Mean Safer
Essential oil-based flea products are widely marketed as gentler alternatives, but the evidence doesn’t support that assumption. A retrospective study covering 2006 to 2008 found that plant-derived flea products containing mixtures of peppermint oil, thyme oil, cinnamon oil, lemongrass oil, and clove oil caused adverse effects in dogs, including lethargy and vomiting. In laboratory testing, even individual essential oils like clove oil caused scratching, itching, and rubbing in roughly 29 percent of treated dogs within 15 minutes of application. For comparison, a standard chemical-based treatment in the same study produced similar or slightly higher reaction rates.
Essential oils also tend to be far less effective at actually killing or repelling fleas and ticks, which creates its own safety problem: a dog left unprotected is at risk for Lyme disease, ehrlichiosis, and other tick-borne illnesses that are far more dangerous than the preventative itself. An ineffective “natural” product isn’t a safer choice if it leaves your dog exposed to disease.
Age and Size Minimums
Most flea and tick products have minimum age and weight requirements. Bravecto, for example, requires dogs to be at least 6 months old and weigh 4.4 pounds or more. Other oral chewables have similar thresholds, typically ranging from 8 weeks to 6 months of age depending on the brand, with minimum weights between 2 and 4.4 pounds.
Very young puppies and toy breeds close to the weight cutoff are the most vulnerable to dosing errors. If your puppy is under 8 weeks old, no oral or topical pesticide product is appropriate. For small puppies between 8 weeks and 6 months, a fipronil-based topical labeled for that age range is generally the most established option, since these products have been used for decades with a well-documented safety margin in small dogs.
Long-Acting Injectables: A New Option
The FDA recently approved Bravecto Quantum, an injectable form of fluralaner that protects against fleas and ticks for 8 to 12 months with a single shot. It’s the first FDA-approved long-acting flea and tick treatment for dogs. The convenience is obvious: no monthly pills to remember, no topical residue on the coat.
The active ingredient is the same isoxazoline used in Bravecto chewables, so the neurologic risk profile is similar. The key difference is that a veterinarian administers the injection directly, which means dosing errors are less likely and your vet can monitor for immediate reactions. Because the drug stays in the body for months, though, if your dog does have an adverse reaction, it can’t simply be discontinued the way you’d stop giving a monthly chew. That’s a tradeoff worth discussing with your vet, especially for dogs that have never taken an isoxazoline product before.
Practical Steps for Choosing
Start with your dog’s individual risk factors. A healthy adult Labrador with no seizure history is a good candidate for nearly any FDA-approved product. A Collie with the MDR1 variant, a senior dog on multiple medications, or a puppy under 6 months needs a more tailored approach.
For dogs with seizure disorders or neurologic concerns, a topical fipronil-based product avoids the systemic exposure that comes with oral isoxazolines. For dogs that swim frequently or live with young children who pet them often, an oral product eliminates the concern about pesticide residue transferring from the coat to skin or water. Topical treatments can wash off into waterways when dogs swim, contributing to contamination of aquatic ecosystems.
Whatever you choose, using the product exactly as labeled is the single most important safety measure. Most adverse reactions trace back to using a product meant for a different species (cat products on dogs, or vice versa), applying the wrong dose size, or doubling up on products without veterinary guidance. A correctly dosed, FDA-approved product matched to your dog’s specific health profile is, by a wide margin, safer than leaving your dog unprotected.